FHIR®: What's in it for healthcare providers?

In this panel discussion leading healthcare providers and technology leaders shared their thoughts on the current state and changing landscape of interoperability, the impact of the CMS' Interoperability & Patient Access (IPA) rule on providers, levels of FHIR® adoption, ground realities, and the potential of FHIR® to enhance business and clinical outcomes.

View Webinar
Login with LinkedIn or Google for a seamless experience
Enter your information

About the Speakers


Dr. Michael Ash

Executive Vice President &
Chief Transformation Officer,
Nebraska Medicine

Jeffrey Springer

Sr. Vice President &
Head of Products,

Jim Buntrock

Vice Chair,
IT, Enterprise Technology Services,
Mayo Clinic

Kalyan Pamarthy
Product Management Lead,
Healthcare & Lifesciences,


There has been a rapidly increasing need for data sharing across the care continuum further accentuated by the COVID pandemic forcing heightened levels of coordination and collaboration. Interoperability is rapidly becoming an undeniable necessity and the evolution of FHIR® is showing a lot of promise in taking interoperability to the next level for improved clinical decisions, care coordination and transparency. With CMS providing the carrot and stick through the Interoperability & Patient Access (IPA) rule, it seems like it’s a matter of time before FHIR® becomes mainstay replacing traditional methods of interoperability.

Learn how FHIR® adoption can make a fragmented healthcare system more integrated, interoperable, secure, and consistent.


Key Learnings

  • Evolving role and landscape of healthcare interoperability
  • Impact of COVID and the CMS Interop Rule on FHIR® adoption
  • Strategic importance and opportunities of FHIR® adoption 
  • Technology strategy for FHIR® adoption to drive business value


" " " " " " "" " " " " " "